Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL1R1 | P14778 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16362369 | 0.88 | IL1R1 (0.40) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL16362309 | 0.85 | IL1R1 (0.40) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL16362314 | 0.83 | IL1R1 (0.37) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL17190942 | 0.82 | IL1R1 (0.38) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL17720391 | 0.81 | L3MBTL1 (0.45) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL17720394 | 0.81 | L3MBTL1 (0.42) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL12596056 | 0.81 | L3MBTL1 (0.37) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL12595993 | 0.81 | L3MBTL1 (0.44) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL12596063 | 0.81 | L3MBTL1 (0.37) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL22549084 | 0.80 | IL1R1 (0.48) | IL1R1KMT2AL3MBTL1MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150303384-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-10-22 | — | — | US | disclosed |
| US-20150303384-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150303384-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNE2, CRY2 | IL1R1 1509/4885KMT2A 1859/4885L3MBTL1 1595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.